BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Biotech Bay

  Rigel Pharmaceuticals, Inc. to Present at UBS Global Life Sciences Conference

  September 17, 2012

   · 

  1 min read
• Biotech Bay

  Varian Medical Systems Publishes 2012 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements

  September 17, 2012

   · 

  2 min read
• Job Trends

  Sanofi (France) Staffers Plot Protests as Job Cuts Loom

  September 17, 2012

   · 

  1 min read
• BioMidwest

  Van Andel Institute Research Symposium Showcases Latest Developments in Parkinson’s Research

  September 17, 2012

   · 

  4 min read
• Biotech Bay

  Pfizer Inc., GlaxoSmithKline and NovaDigm Therapeutics ' Vaccine for Staph More Lethal Than Skin Cancer Tested

  September 17, 2012

   · 

  1 min read
• Job Trends

  Aptalis Pharmaceutical Technologies Plans Growth, to Create 75 New Jobs

  September 17, 2012

   · 

  1 min read
• Drug Development

  Jennerex, Inc. Presents Positive Phase 2 Trial of JX-594

  September 17, 2012

   · 

  9 min read
• Drug Development

  Anthera Pharmaceuticals, Inc. Announces the Advancement of Blisibimod into Phase 3 Development for Patients With Systemic Lupus Erythematosus (SLE)

  September 17, 2012

   · 

  4 min read
• Business

  Allergy Therapeutics plc Preliminary Results for the Year Ended 30 June 2012

  September 17, 2012

   · 

  2 min read
• Pharm Country

  Elusys Therapeutics, Inc. Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax

  September 17, 2012

   · 

  4 min read